The AstraZeneca CSPC weight-loss deal includes $1.2bn upfront and milestone payments tied to obesity drugs, expanding AstraZeneca China investment strategy.
Seamless Therapeutics and Eli Lilly Hearing Loss Collaboration
The Seamless Therapeutics Eli Lilly hearing loss collaboration includes a global research and licensing deal worth up to $1.12bn to advance genetic medicines.
Drugmakers Turn to AI To Speed Up Trials and Submissions
Drugmakers turn to AI to speed trials and regulatory submissions, cutting timelines for site selection, and documentation across drug development programs.
Vetter Pharma to Build New Manufacturing Site in Germany
Vetter Pharma manufacturing site in Germany marks a €480 million investment in Saarland, expanding injectable drug production and creating up to 2,000 jobs.
